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for leukemogenesis. Third, although the available data
argues against post-lysis artifacts, this is very difficult
to definitively exclude short of mutating the putative
cleavage sites, and as noted above this may be difficult
given the presence of several sites. Fourth, it is not clear MoMLV Reverse Transcriptase
where or how NE gains access to PML-RAR, as they Regulates Its Own Expression
are thought to reside in different cellular compartments.
Last, the human APL cell line NB4 containing the PML-
RAR expresses the full-length PML-RAR fusion pro-
tein, and lacks NE activity. These data provide further A precise ratio of Gag:Gag-Pol expression is required
correlation between NE activity and cleavage, but raise for assembly of infectious retroviral virions. In this is-
the question of why a leukemic cell line derived from a sue of Cell, Orlova et al. show that MoMLV reverse
primary leukemia lacks this activity if it is critical for transcriptase binds the translation release factor
leukemogenesis. eRF1, and that this interaction promotes translation
Nonetheless, these findings are provocative, and war- readthrough to make Gag-Pol.
rant additional experimentation to validate the findings,
and to determine the extent to which these observations The retroviral gene gag is expressed both as an indepen-
can be extrapolated to other leukemogenic fusion genes. dent polyprotein and as a fusion with the polyprotein
One enticing possibility is that proteolytic processing encoded by the gene pol. The link between the structural
plays a more important role than previously appreciated components of the virion found in Gag and the viral
in human leukemias. In addition to PML-RAR, there is enzymes found in Pol ensures that these enzymes are
a predilection among other leukemogenic fusion onco- packaged in newly formed viral particles. But why does
genes for association with specific AML subtypes. For the virus require two forms of Gag? Exclusive expression
example, MLL fusions are frequently associated with of Gag results in the assembly and release of virus-like
myelomonocytic leukemias—it may be of interest to see particles. However, these particles fail to infect cells
if there are differences in MLL cleavage by Taspase 1 because they lack the enzymes required for maturation
in this cellular context. Perhaps the most intriguing as- of the virion and for replication. On the other hand, over-
pect of these two reports is the unexpectedly important expression of Gag-Pol inhibits assembly, possibly due
role that proteolytic processing plays in these develop- to the steric constraints of having Pol on the C terminus
mental and leukemogenic processes. Finally, these data of Gag (Swanstrom and Wills, 1997), and can prevent
suggest that certain proteases should be explored as the packaging of two copies of the viral RNA (Shehu-
potential therapeutic targets in leukemia. Xhilaga et al., 2001). Thus, a delicate balance between
the expression of Gag and Gag-Pol is critical for infec-
tion and is carefully maintained by most retroviruses at
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immunodeficiency virus (HIV), the gag and pol genes
share an overlapping reading frame, and a1 frameshift
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mRNA requirements for gag-pol readthrough, less is new cells. Whereas virions derived from the RT-minus
known about the regulatory mechanisms that control and eRF1 interaction-deficient mutants failed to pro-
this process. duce any progeny virus even after two weeks, viral parti-
In this issue of Cell, Orlova et al. (2003) identify eukary- cles derived from the wild-type vector were highly infec-
otic release factor 1 (eRF1) as a cellular protein that tious. Thus, the effect of RT on gag-pol readthrough is
interacts with MoMLV reverse transcriptase (RT), a viral dependent on an interaction between RT and eRF1.
enzyme encoded by pol. eRF1 has an integral role in By demonstrating that an MoMLV-RT upregulates its
the normal termination of translation (Kisselev et al., own expression through a specific interaction with the
2003). When the moving ribosome encounters a stop host translation termination machinery, Orlova et al.
codon, eRF1 binds in the A-site and, with the ribosomal have discovered a new way in which retroviruses manip-
RNA, facilitates the cleavage of the peptidyl-tRNA bond ulate cellular processes to their advantage. This exciting
by an unknown mechanism to release the newly synthe- discovery raises many questions about the mechanism
sized protein. Given the role of eRF1 in translation termi- by which the RT-eRF1 interaction affects stop codon
nation, Orlova et al. set out to further investigate the suppression; like all interactions in such feedback loops,
potential interaction between eRF1 and RT and whether the key answers lie in the binding equilibriums. What is
or not RT is involved in the regulation of its own ex- the effect of RT on the affinity of eRF1 for mRNA, the
pression. ribosome, and the other translation release factor,
The authors first present evidence supporting an inter- eRF3? What is the affinity of RT for eRF1, and do other
action between RT and eRF1 both in vitro and in vivo. cellular and viral cofactors play a role in this regulatory
In vitro, RT is retrieved from solution by an eRF1-gluta- circuit? A biophysical examination of this system could
thione S transferase (GST) fusion bound to glutathione explain even further how MoMLV masters the delicate
beads. Both domains of RT, the DNA polymerase do- regulation of Gag and Gag-Pol expression.
main and the RNase H domain, appear to interact with
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and H.E. Varmus, eds. (Cold Spring Harbor, NY: Cold Spring Harborof Gag-Pol in MoMLV infected cells, the authors trans-
Laboratory Press), pp. 263–334.fected cells with proviral DNA lacking the RT gene. In
the absence of RT, the expression level of Gag-Pol is
not detectable by Western blot analysis, whereas the
expression of Gag is equal to that observed in cells
transfected with the wild-type provirus. These combined
HtrA2/Omi, a Sheep inobservations, that increasing RT can increase read-
through at the gag-pol junction and that the removal of Wolf’s Clothing
RT prevents readthrough, strongly support a role for RT
in the regulation of its own synthesis.
Is the regulatory role of RT related to its interaction
with eRF1? To answer this question, Orlova et al. iso-
Mammalian mitochondrial HtrA2/Omi was originallylated mutants of RT that fail to interact with eRF1. Similar
described as an apoptosis inducer, but rather thanto the effect of removing the RT gene entirely, cells
having extra cells, mice with mutant HtrA2/Omi suffertransfected with proviral DNA containing these RT muta-
from a neurodegenerative disease due to progressivetions failed to express the Gag-Pol protein. The Gag
mitochondrial damage. This suggests that instead ofprotein was expressed at wild-type levels in these cells
promoting cell death by antagonizing inhibitor of apo-but remained unprocessed, consistent with the fact that
ptosis (IAP) proteins, the primary function of HtrA2/protease is encoded by pol. The viral particles produced
Omi is to handle misfolded proteins in the mito-from these mutant proviral vectors, and from the RT-
minus proviral vector, were harvested and used to infect chondria.
